Patent · US Active

Composition for reducing senescence of cell or subject including BRAF inhibitor and use thereof

US9763923B2 · kind B2 · utility

1Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 2, 2016
Grant dateSep 19, 2017
Priority date
Expiry dateMay 2, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61Q19/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided is a method of reducing senescence in a cell or subject, or treating or preventing a symptom or disease associated therewith, by administering a BRAF inhibitor to the cell or subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.